Medtronic PLC MDT

Morningstar Rating
$86.38 −0.06 (0.07%)
View Full Chart

Company Report

Medtronic Is Well Positioned for 2027 Thanks to Its Lineup of New Products

Medtronic's standing as the largest pure-play medical-device maker remains a force to be reckoned with in the medical technology landscape. Medtronic's diversified product portfolio aimed at a wide range of chronic diseases spans therapeutic areas including cardiac, spine, chronic pain, as well as various products for acute care. This has put Medtronic in a strong position as a major vendor to hospital customers.

Price vs Fair Value

MDT is trading at a LOCK|@llW!k? premium.
Price
$86.44
Fair Value
TH!
Uncertainty
LOCK|Ng@&
1-Star Price
LOCK|!.%c
5-Star Price
LOCK|.F
Economic Moat
LOCK|pm$<
Capital Allocation
LOCK|WM?Jbp

Bulls Say, Bears Say

Bulls

Medtronic has historically held roughly 50% share in its core heart devices. It's also the market leader in spinal products, insulin pumps, and neuromodulators for chronic pain.

Bears

Medtronic's Hugo robot will be going up against the industry standard set by Intuitive's da Vinci system, which dominates soft tissue robotic surgery.

News

Articles & Videos

Trading Information

Previous Close Price
$86.44
Day Range
$85.59–87.94
52-Week Range
$73.31–106.33
Bid/Ask
$86.25 / $87.49
Shares Outstanding
1.28B
Market Cap
$110.47B
Volume/Avg
33M / 9M

Key Statistics

Price/Earnings (Normalized)
15.27
Price/Sales
2.96
Dividend Yield (Trailing)
3.31%
Dividend Yield (Forward)
3.33%
Dividend Payment Schedule
Jan, Apr, Jul, Oct
Total Yield
3.49%

Company Profile

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, surgical robots, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Value
Total Number of Employees
95,000

Competitors

Valuation

Metric
MDT
BSX
ABT
Price/Earnings (Normalized)
15.2713.4718.37
Price/Book Value
2.202.513.27
Price/Sales
2.963.073.62
Price/Cash Flow
12.4012.4615.44
Price/Earnings
MDT
BSX
ABT

Financial Strength

Metric
MDT
BSX
ABT
Quick Ratio
1.290.560.97
Current Ratio
2.071.241.38
Interest Coverage
10.1211.5610.40
Quick Ratio
MDT
BSX
ABT

Profitability

Metric
MDT
BSX
ABT
Return on Assets (Normalized)
8.31%11.01%9.71%
Return on Equity (Normalized)
15.59%19.82%17.95%
Return on Invested Capital (Normalized)
10.57%14.09%13.03%
Return on Assets
MDT
BSX
ABT

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|f!>?nTLOCK|?sTQ$167B
Stryker Corp
SYK
LOCK|jRmszgxLOCK|T#%$105B
Boston Scientific Corp
BSX
LOCK|#<!Zwj!LOCK|Gt!&$63B
Edwards Lifesciences Corp
EW
LOCK|gMlx>QBLOCK|p$?R$49B
DexCom Inc
DXCM
LOCK|%^WR#m#MLOCK|<#q#%$33B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|SGn>M!LOCK|fS$29B
Koninklijke Philips NV ADR
PHG
LOCK|#C@LOCK|pw$23B
Steris PLC
STE
LOCK|V!czDLSLOCK|L%DZd$20B
Zimmer Biomet Holdings Inc
ZBH
LOCK|!jjk<@$gLOCK|V<$17B

Sponsor Center